or
Remember me
Back
Yes. Tilray paid $250 million for a company that would have declared bankruptcy if they hadn't. Hexo contributed $10 million in revenue last quarter. Hexo had reported NEGATIVE Gross Profit (that's the profit after direct costs are deducted - but before operating costs) - it cost Hexo more to produce a product than what they sold for t for.
About all Tilray got was done idle empty production space thry didn't need - and are still paying for. Tilray is certainly not a lot better in controlling costs And Zenabis, the Hexo sub that THEY paid $250 millon for? They owed SnDL $60 million - didn't have it declared bankruptcy. couldn't cover the tab and allowed SNDL to get Zenabis for Pennie's - including a state of the art EUGMP facility - which had accounted for 90% of hexos international sales. Nothing HAS changed - incompetence - you were right to suggest it's time for a new CEO
Tilray Brands Board contracted a Virus. Source Hexo, Zennabis.
Tilray Brands now owns Hexo, which was a great move by Tilray Brands. Approved by the shareholders.
Receive investor kits and email updates from Stockhouse and directly from these companies.
At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!